Chemoinformaics analysis of trans-gamma-Cadinene
| Molecular Weight | 204.357 | nRot | 1 |
| Heavy Atom Molecular Weight | 180.165 | nRig | 12 |
| Exact Molecular Weight | 204.188 | nRing | 2 |
| Solubility: LogS | -5.607 | nHRing | 0 |
| Solubility: LogP | 5.11 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 41.053 |
| nHD | 0 | BPOL | 24.077 |
| QED | 0.548 |
| Synth | 4.095 |
| Natural Product Likeliness | 2.994 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.003 |
| CACO-2 | -4.397 |
| MDCK | 0.0000126 |
| BBB | 0.952 |
| PPB | 0.953625 |
| VDSS | 2.878 |
| FU | 0.0280215 |
| CYP1A2-inh | 0.293 |
| CYP1A2-sub | 0.601 |
| CYP2c19-inh | 0.162 |
| CYP2c19-sub | 0.883 |
| CYP2c9-inh | 0.451 |
| CYP2c9-sub | 0.707 |
| CYP2d6-inh | 0.021 |
| CYP2d6-sub | 0.693 |
| CYP3a4-inh | 0.316 |
| CYP3a4-sub | 0.478 |
| CL | 14.178 |
| T12 | 0.06 |
| hERG | 0.028 |
| Ames | 0.013 |
| ROA | 0.039 |
| SkinSen | 0.044 |
| Carcinogencity | 0.511 |
| EI | 0.582 |
| Respiratory | 0.037 |
| NR-Aromatase | 0.003 |
| Antiviral | Yes |
| Prediction | 0.905931 |